Ho Bae

1.0k total citations
20 papers, 204 citations indexed

About

Ho Bae is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Ho Bae has authored 20 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in Ho Bae's work include Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (5 papers). Ho Bae is often cited by papers focused on Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (5 papers). Ho Bae collaborates with scholars based in United States, South Korea and China. Ho Bae's co-authors include Tse–Ling Fong, Brian T. Lee, Sue Lee, Calvin Q. Pan, Linda S. Chan, Huy N. Trinh, Lillian Lou, Sing Chan, Se Woon Choi and Hie‐Won Hann and has published in prestigious journals such as Gastroenterology, PLoS ONE and Journal of Hepatology.

In The Last Decade

Ho Bae

18 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ho Bae United States 7 154 148 47 17 12 20 204
Dimas Alexandre Kliemann Brazil 7 105 0.7× 64 0.4× 70 1.5× 13 1.1× 17 149
Mark Sulkowski United States 4 268 1.7× 257 1.7× 20 0.4× 20 1.7× 6 310
Habiba Kamal Sweden 7 131 0.9× 123 0.8× 18 0.4× 11 0.9× 16 188
Annika Kau Germany 3 371 2.4× 372 2.5× 43 0.9× 9 0.8× 4 410
Amanda Lopes France 9 105 0.7× 69 0.5× 34 0.7× 4 0.3× 14 158
M.J. Jimenez-Exposito Spain 7 275 1.8× 258 1.7× 91 1.9× 7 0.6× 13 318
Sergio Veloso Spain 7 121 0.8× 122 0.8× 73 1.6× 25 2.1× 10 199
Tomoyuki Kuramitsu Japan 8 208 1.4× 212 1.4× 34 0.7× 10 0.8× 22 260
K.E. Sherman United States 8 136 0.9× 163 1.1× 57 1.2× 8 0.7× 19 196
Melissa Shaughnessy United States 5 214 1.4× 284 1.9× 138 2.9× 12 1.0× 5 289

Countries citing papers authored by Ho Bae

Since Specialization
Citations

This map shows the geographic impact of Ho Bae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho Bae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho Bae more than expected).

Fields of papers citing papers by Ho Bae

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho Bae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho Bae. The network helps show where Ho Bae may publish in the future.

Co-authorship network of co-authors of Ho Bae

This figure shows the co-authorship network connecting the top 25 collaborators of Ho Bae. A scholar is included among the top collaborators of Ho Bae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho Bae. Ho Bae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Juon, Hee‐Soon, et al.. (2025). Perceived HBV‐Related Stigma Is Associated With Lower Antiviral Medication Adherence in Patients With Chronic Hepatitis B. Journal of Viral Hepatitis. 32(3). e70010–e70010. 3 indexed citations
2.
Luo, Rui, Zhong Ye, Qiang Wei, et al.. (2023). Genomic characterization of early-stage hepatocellular carcinoma patients with Hepatitis B using circulating tumor DNA. Clinics and Research in Hepatology and Gastroenterology. 47(7). 102161–102161. 5 indexed citations
3.
Pan, Calvin Q., Nezam H. Afdhal, Victor Ankoma‐Sey, et al.. (2022). First‐line therapies for hepatitis B in the United States: A 3‐year prospective and multicenter real‐world study after approval of tenofovir alefenamide. Hepatology Communications. 6(8). 1881–1894. 6 indexed citations
4.
5.
Reddy, K. Rajender, Michael P. Curry, Ho Bae, et al.. (2020). Longer-term experience with tenofovir alafenamide (TAF) in HBV-infected patients; changes in EGFR, FIB4, ALT, and DNA suppression. Journal of Hepatology. 73. S881–S882. 4 indexed citations
6.
Curry, Michael P., Ho Bae, Douglas T. Dieterich, et al.. (2020). Differential tenofovir alafenamide (TAF) adoption in HBV-infected populations; assessment of care in US clinical practice. Journal of Hepatology. 73. S876–S876. 2 indexed citations
7.
Lee, Brian T., et al.. (2020). Bone and renal safety profile at 72 weeks after switching to tenofovir alafenamide in chronic hepatitis B patients. JGH Open. 5(2). 258–263. 15 indexed citations
8.
9.
10.
Bae, Ho, Young‐Suk Lim, Huy N. Trinh, et al.. (2020). S1126 Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Hepatic Impairment: Week 48 Results From a Phase 2 Open Label Study. The American Journal of Gastroenterology. 115(1). S566–S567. 2 indexed citations
11.
12.
Wang, Chun, Hie‐Won Hann, Zhong Ye, et al.. (2016). Prospective evidence of a circulating microRNA signature as a non-invasive marker of hepatocellular carcinoma in HBV patients. Oncotarget. 0(0). 14 indexed citations
13.
Fong, Tse–Ling, Danny Chu, Eddie C. Cheung, et al.. (2015). Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir. Digestive Diseases and Sciences. 60(11). 3465–3472. 15 indexed citations
14.
Chan, Linda S., et al.. (2014). Long-Term Treatment with Tenofovir in Asian-American Chronic Hepatitis B Patients Is Associated with Abnormal Renal Phosphate Handling. Digestive Diseases and Sciences. 60(2). 566–572. 35 indexed citations
15.
Pan, Calvin Q., et al.. (2014). Efficacy and Safety of Tenofovir Disoproxil Fumarate in Asian-Americans with Chronic Hepatitis B in Community Settings. PLoS ONE. 9(3). e89789–e89789. 19 indexed citations
16.
Pan, Calvin Q., Huy N. Trinh, Ho Bae, et al.. (2011). Tenofovir Disoproxil Fumarate (TDF) Shows Similar Virologic Suppression and Safety Between Asians and Non-Asians With Chronic Hepatitis B (CHB). Gastroenterology. 140(5). S–896. 3 indexed citations
17.
Kim, Sang, et al.. (2006). Development of Real-time Defect Detection Algorithm for High-speed Steel Bar in Coil(BIC). 2006 SICE-ICASE International Joint Conference. 2495–2498. 17 indexed citations
18.
Chae, Shung Chull, et al.. (2000). Short-term prognostic value of CRP in the patients with acute coronary syndrome. Sunhwan'gi. 30(11). 1387–1387. 6 indexed citations
19.
Shin, Seung Chul, et al.. (2000). The Early Result of Primary NIR Stenting in Acute Myocardial Infarction. Sunhwan'gi. 30(5). 563–563.
20.
Bae, Ho. (1990). A NEW METHOD FOR MEASURING THE DEGRADATION LEVEL OF TRANSFORMER INSULATING OIL IN SERVICE. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimas Alexandre Kliemann Breakdown of academic impact, for papers by Mark Sulkowski Breakdown of academic impact, for papers by Habiba Kamal Breakdown of academic impact, for papers by Annika Kau Breakdown of academic impact, for papers by Amanda Lopes Breakdown of academic impact, for papers by M.J. Jimenez-Exposito Breakdown of academic impact, for papers by Sergio Veloso Breakdown of academic impact, for papers by Tomoyuki Kuramitsu Breakdown of academic impact, for papers by K.E. Sherman Breakdown of academic impact, for papers by Melissa Shaughnessy
Rankless by CCL
2026